SURFACTANTS
Competition remains heavily influenced by volume and price. This creates a structural vulnerability. LABSA and other widely used surfactants are exposed to movements in their underlying feedstocks, including palm-derived and petrochemical inputs.
With the global FAO Vegetable Oil Price Index recently reaching a four-year high, pressures like this are difficult to treat as isolated events. The lesson India is learning in real time is that growth does not by itself de-risk an industry, but composition can.
Where the next wave of value is migrating
The more interesting opportunity lies in the expansion of surfactants beyond their traditional applications. Globally, the speciality surfactants market is estimated at around $ 37 billion and is projected to reach over $ 49 billion by 2033. More importantly, the market is increasingly being shaped as a functional-ingredient industry rather than simply a commodity one.
This has wide-ranging implications across sectors. In pharmaceuticals, they can help stabilise formulations and improve drug delivery. In energy, they are used in processes such as enhanced oil recovery, where their surface-active properties can improve oil displacement. In advanced materials, they can influence processes such as wetting, dispersion and surface modification.
India provides a strong backdrop for this transition. Between 2024 and 2026, pharmaceutical exports grew by 9.4 % to $ 30.47 billion, textile exports grew by 2.1 % and 674 wells were drilled.
The same molecule is being adapted to solve different problems, and that is where the premium increasingly lies. Producing the largest tonnage is no longer enough to ensure growth and build resilience; it is now a question of who can solve the harder, narrower technical problems.
What this looks like in practice
This transition requires a willingness to invest simultaneously in scale and specialisation, not one at the expense of the other. The early signs of this are already visible in India.
Godrej has brought a commercialscale, fermentation-derived sophorolipid biosurfactant platform to market, spanning personal care, home care and industrial cleaning. What is significant here is that a familiar category of chemistry being engineered around a broader set of performance requirements, proof that the shift from commodity to functional chemistry is achievable at commercial scale, not just in pilot volumes.
The broader signal for the sector, though, is one on capacity investment. Scale and specialisation do not have to compete for the same capital. Primary surfactant capacity, feedstock integration and speciality chemical investment can be planned within a single programme rather than treated as sequential bets, where a company waits to prove one before committing to the other.
For surfactant manufacturers, the takeaway is straightforward: manufacturing depth wins today’ s markets, application science wins tomorrow ' s. Neither is optional and increasingly it is the ability to build both at once that decides who leads.
What it will take to scale
The next step is to make this transition an industry-wide opportunity, not an isolated one. Domestic capacity is already evolving. Investments in ethoxylation and related processing infrastructure are creating the means to support more sophisticated formulations and customised chemistry, rather than simply adding commodity volume.
Standards will matter too. India’ s Ecomark Rules provide a framework for environmental claims to be assessed and labelled, creating greater scope for biobased and fermentation-derived products to
differentiate themselves through verifiable attributes rather than broad sustainability claims.
However, scaling will take more than infrastructure and standards. Manufacturers and formulators will need to work more closely together to shorten qualification and development cycles. Speciality chemistry succeeds when the producer understands the application ' s problem deeply enough to design around it – something that requires collaboration from the get-go, before a product reaches the market.
The Gujarat LABSA disruption offers a useful reminder of what is at stake. When a business is reliant on one molecule and one cost structure, it has little cushion when something beyond its control changes.
India’ s surfactants opportunity over the next decade will be defined by how many problems its chemistry can solve. For a country seeking to move up the value chain in chemicals, this is a significant opportunity, and one whose early chapters are already being written. ●
J j
Shreya Singh
ASSISTANT MANAGER
GODREJ INDUSTRIES shreya. singh @ godrejinds. com www. godrejchemicals. com
NOV / DEC 2026 SPECCHEMONLINE. COM
39